Tjulandin, Sergei A.

Top Publications

Top Publications Authored or Co-Authored by "Tjulandin, Sergei A."

• Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): A randomised, multicentre, open-label, non-inferiority phase 3 study

  The Lancet Oncology, Volume 15, No. 6, Year 2014, Citations 401
• Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

  Annals of Oncology, Volume 32, No. 8, Year 2021, Citations 330
• Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer

  European Journal of Cancer, Volume 68, Year 2016, Citations 56
• Randomized phase II non-inferiority study (no16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer

  Annals of Oncology, Volume 23, No. 3, Year 2012, Citations 13
• Frequency of S492R mutations in the epidermal growth factor receptor: analysis of plasma DNA from patients with metastatic colorectal cancer treated with panitumumab or cetuximab monotherapy

  Cancer Biology and Therapy, Volume 21, No. 10, Year 2020, Citations 11